Eli Lilly antibody drug fails in a COVID-19 study; other studies go on
U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t...
Miguel Perales M.D.
Eli Lilly antibody drug fails in a #COVID19 study - need to continue to #WearAMask #SocialDistancing
Toni Choueiri, MD
Just now: No more hospitalized patients will receive #Lilly Antibody bamlanivimab to #COVID19 as it “is unlikely to help hospitalized COVID-19 patients recover from this advanced stage of their disease."